Want to see BSX full AI Analyst Report?

Boston Scientific (BSX) Stock Forecast & Price Target

4,519 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

BSX Analyst Ratings

Strong Buy

21 Buy

2 Hold

0 Sell

Based on 23 analysts giving stock ratings to

Boston

Scientific

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

BSX Stock 12 Month Forecast

Average Price Target

$70.48

▲(9.72% Upside)

Based on 23 Wall Street analysts offering 12 month price targets for Boston Scientific in the last 3 months. The average price target is $70.48 with a high forecast of $95.00 and a low forecast of $55.00. The average price target represents a 9.72% change from the last price of $64.23.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"42":"$42","107":"$107","58.25":"$58.3","74.5":"$74.5","90.75":"$90.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":95,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$95.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":70.47619047619048,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$70.48</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":55,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$55.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[42,58.25,74.5,90.75,107],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,43.06,47.05538461538462,51.050769230769234,55.04615384615385,59.041538461538465,63.036923076923074,67.0323076923077,71.0276923076923,75.02307692307693,79.01846153846154,83.01384615384615,87.00923076923077,91.00461538461539,{"y":95,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,43.06,45.168937728937735,47.27787545787546,49.38681318681319,51.49575091575092,53.60468864468865,55.71362637362638,57.82256410256411,59.93150183150183,62.040439560439566,64.1493772893773,66.25831501831502,68.36725274725276,{"y":70.47619047619048,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,43.06,43.97846153846154,44.89692307692308,45.815384615384616,46.73384615384616,47.652307692307694,48.57076923076923,49.48923076923077,50.40769230769231,51.326153846153844,52.244615384615386,53.16307692307692,54.081538461538464,{"y":55,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":104.78,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 54,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":105.41,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 42,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":106.66,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 52,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":95.85,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 60,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":100.72,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 61,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":101.01,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 52,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":95.35,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":91.87,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 66,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.22,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 86,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":62,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 98,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":56.5,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 89,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.98,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 71,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43.06,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 45,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$95.00

Average Price Target$70.48

Lowest Price Target$55.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Anthony Petrone

Mizuho Securities

$90→$70

Buy

8.98%

Upside

Reiterated

07/15/26

Boston Scientific price target lowered to $70 from $90 at MizuhoBoston Scientific price target lowered to $70 from $90 at Mizuho

Josh Jennings

TD Cowen

$61

Buy

-5.03%

Downside

Reiterated

07/14/26

Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (NASDAQ: TNDM) and Boston Scientific (NYSE: BSX)

David Roman

Goldman Sachs

$71→$57

Buy

-11.26%

Downside

Reiterated

07/14/26

Goldman Sachs Keeps Their Buy Rating on Boston Scientific (BSX)

Travis Steed

Bank of America Securities

$61

Buy

-5.03%

Downside

Reiterated

07/14/26

Analysts Are Bullish on These Healthcare Stocks: Boston Scientific (BSX), Ligand Pharma (LGND)

Shagun Singh Chadha

RBC Capital

$100→$85

Buy

32.34%

Upside

Reiterated

07/13/26

Boston Scientific price target lowered to $85 from $100 at RBC CapitalBoston Scientific price target lowered to $85 from $100 at RBC Capital

Marie Thibault

BTIG

$65

Buy

1.20%

Upside

Reiterated

07/10/26

BTIG Remains a Buy on Boston Scientific (BSX)

Michael Matson

Needham

$77→$57

Buy

-11.26%

Downside

Assigned

07/08/26

Analysts Offer Insights on Healthcare Companies: Regeneron (NASDAQ: REGN), Newron Pharmaceuticals SpA (Other OTC: NWPHF) and Boston Scientific (NYSE: BSX)

Vijay Kumar

Evercore ISI

$78→$65

Buy

1.20%

Upside

Reiterated

07/06/26

Boston Scientific price target lowered to $65 from $78 at Evercore ISIBoston Scientific price target lowered to $65 from $78 at Evercore ISI

Joanne Wuensch

Citi

$70

Buy

8.98%

Upside

Reiterated

07/06/26

Citi Reaffirms Their Buy Rating on Boston Scientific (BSX)

Rick Wise

Stifel Nicolaus

$75→$65

Buy

1.20%

Upside

Reiterated

06/25/26

Boston Scientific price target lowered to $65 from $75 at StifelBoston Scientific price target lowered to $65 from $75 at Stifel

Matthew Taylor

Jefferies

$100→$67

Buy

4.31%

Upside

Assigned

06/24/26

Boston Scientific price target lowered to $67 from $100 at JefferiesBoston Scientific price target lowered to $67 from $100 at Jefferies

Matthew O'Brien

Piper Sandler

$90→$65

Buy

1.20%

Upside

Reiterated

06/12/26

Boston Scientific price target lowered to $65 from $90 at Piper SandlerBoston Scientific price target lowered to $65 from $90 at Piper Sandler

Richard Newitter

Truist Financial

$85→$64

Buy

-0.36%

Downside

Assigned

06/04/26

Boston Scientific (BSX) Receives a Buy from Truist Financial

William Plovanic

Canaccord Genuity

$71→$70

Buy

8.98%

Upside

Reiterated

06/01/26

Boston Scientific price target lowered to $70 from $71 at CanaccordBoston Scientific price target lowered to $70 from $71 at Canaccord

Michael Polark

Wolfe Research

―

Hold

―

Downgraded

05/29/26

Boston Scientific downgraded to Peer Perform from Outperform at Wolfe ResearchBoston Scientific downgraded to Peer Perform from Outperform at Wolfe Research

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Anthony Petrone

Mizuho Securities

$90→$70

Buy

8.98%

Upside

Reiterated

07/15/26

Boston Scientific price target lowered to $70 from $90 at MizuhoBoston Scientific price target lowered to $70 from $90 at Mizuho

Josh Jennings

TD Cowen

$61

Buy

-5.03%

Downside

Reiterated

07/14/26

Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (NASDAQ: TNDM) and Boston Scientific (NYSE: BSX)

David Roman

Goldman Sachs

$71→$57

Buy

-11.26%

Downside

Reiterated

07/14/26

Goldman Sachs Keeps Their Buy Rating on Boston Scientific (BSX)

Travis Steed

Bank of America Securities

$61

Buy

-5.03%

Downside

Reiterated

07/14/26

Analysts Are Bullish on These Healthcare Stocks: Boston Scientific (BSX), Ligand Pharma (LGND)

Shagun Singh Chadha

RBC Capital

$100→$85

Buy

32.34%

Upside

Reiterated

07/13/26

Boston Scientific price target lowered to $85 from $100 at RBC CapitalBoston Scientific price target lowered to $85 from $100 at RBC Capital

Marie Thibault

BTIG

$65

Buy

1.20%

Upside

Reiterated

07/10/26

BTIG Remains a Buy on Boston Scientific (BSX)

Michael Matson

Needham

$77→$57

Buy

-11.26%

Downside

Assigned

07/08/26

Analysts Offer Insights on Healthcare Companies: Regeneron (NASDAQ: REGN), Newron Pharmaceuticals SpA (Other OTC: NWPHF) and Boston Scientific (NYSE: BSX)

Vijay Kumar

Evercore ISI

$78→$65

Buy

1.20%

Upside

Reiterated

07/06/26

Boston Scientific price target lowered to $65 from $78 at Evercore ISIBoston Scientific price target lowered to $65 from $78 at Evercore ISI

Joanne Wuensch

Citi

$70

Buy

8.98%

Upside

Reiterated

07/06/26

Citi Reaffirms Their Buy Rating on Boston Scientific (BSX)

Rick Wise

Stifel Nicolaus

$75→$65

Buy

1.20%

Upside

Reiterated

06/25/26

Boston Scientific price target lowered to $65 from $75 at StifelBoston Scientific price target lowered to $65 from $75 at Stifel

Matthew Taylor

Jefferies

$100→$67

Buy

4.31%

Upside

Assigned

06/24/26

Boston Scientific price target lowered to $67 from $100 at JefferiesBoston Scientific price target lowered to $67 from $100 at Jefferies

Matthew O'Brien

Piper Sandler

$90→$65

Buy

1.20%

Upside

Reiterated

06/12/26

Boston Scientific price target lowered to $65 from $90 at Piper SandlerBoston Scientific price target lowered to $65 from $90 at Piper Sandler

Richard Newitter

Truist Financial

$85→$64

Buy

-0.36%

Downside

Assigned

06/04/26

Boston Scientific (BSX) Receives a Buy from Truist Financial

William Plovanic

Canaccord Genuity

$71→$70

Buy

8.98%

Upside

Reiterated

06/01/26

Boston Scientific price target lowered to $70 from $71 at CanaccordBoston Scientific price target lowered to $70 from $71 at Canaccord

Michael Polark

Wolfe Research

―

Hold

―

Downgraded

05/29/26

Boston Scientific downgraded to Peer Perform from Outperform at Wolfe ResearchBoston Scientific downgraded to Peer Perform from Outperform at Wolfe Research

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

TARAProtara Therapeutics

BKDBrookdale Senior Living

EYPTEyePoint Pharmaceuticals

ZVRAZevra Therapeutics

DFTXDefinium Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Boston Scientific

3 Months

Marie ThibaultBTIG

Success Rate

26/39 ratings generated profit

Average Return

+1.83%

Copying Marie Thibault's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +1.83% per trade.

1 Year

Jayson BedfordRaymond James

Success Rate

40/54 ratings generated profit

Average Return

+12.19%

Copying Jayson Bedford's trades and holding each position for 1 Year would result in 74.07% of your transactions generating a profit, with an average return of +12.19% per trade.

2 Years

Jayson BedfordRaymond James

Success Rate

42/54 ratings generated profit

Average Return

+23.26%

Copying Jayson Bedford's trades and holding each position for 2 Years would result in 77.78% of your transactions generating a profit, with an average return of +23.26% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BSX Analyst Recommendation Trends

Rating

Mar 26

Apr 26

May 26

Jun 26

Jul 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, BSX has received 45 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. BSX average Analyst price target in the past 3 months is 70.48.

Each month's total comprises the sum of three months' worth of ratings.

BSX Financial Forecast

BSX Earnings Forecast

Next quarter’s earnings estimate for BSX is $0.83 with a range of $0.80 to $0.84. The previous quarter’s EPS was $0.80. BSX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year BSX has Performed in-line its overall industry.

BSX Sales Forecast

Next quarter’s sales forecast for BSX is $5.37B with a range of $5.28B to $5.42B. The previous quarter’s sales results were $5.20B. BSX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year BSX has Performed in-line its overall industry.

BSX Stock Forecast FAQ

What is BSX’s average 12-month price target, according to analysts?

Based on analyst ratings, Boston Scientific’s 12-month average price target is 70.48.

What is BSX’s upside potential, based on the analysts’ average price target?

Boston Scientific has 9.72% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is BSX a Buy, Sell or Hold?

Boston Scientific has a consensus rating of Strong Buy which is based on 21 buy ratings, 2 hold ratings and 0 sell ratings.

What is Boston Scientific’s price target?

The average price target for Boston Scientific is 70.48. This is based on 23 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $95.00 ,the lowest forecast is $55.00. The average price target represents 9.72% Increase from the current price of $64.23.

What do analysts say about Boston Scientific?

Boston Scientific’s analyst rating consensus is a Strong Buy. This is based on the ratings of 23 Wall Streets Analysts.

How can I buy shares of BSX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Boston Scientific (BSX) Stock Forecast & Price Target

BSX Analyst Ratings

BSX Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Boston Scientific

BSX Analyst Recommendation Trends

BSX Financial Forecast

BSX Earnings Forecast

BSX Sales Forecast

BSX Stock Forecast FAQ

Detailed List of Analyst Forecasts